Original Article
Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line
Zhiyong He, Fusheng Gong, Jinrong Liao, Qiang Wang, Ying Su, Chao Chen, Jinghui Lin, Ren-Jang Lin